It may include assessing the patients readiness to quit, discussing the health risks of continued tobacco use, reviewing cessation strategies, recommending pharmacotherapy, providing motivational interviewing around quitting, and setting quit dates
doi:10.2105/AJPH.2011.300292
In this section of this proposed rule, we identify proposed adjustments to the estimated burden for partial QP elections that will be submitted to OMB for review under control number 0938-1314 (CMS-10621), as summarized in Tables 78 and 79
117-169, enacted August 16, 2022) established new requirements under which drug manufacturers must pay inflation rebates if they raise their prices for certain Part B and Part D drugs faster than the rate of inflation
Therefore, we are not proposing any adjustments in burden because we assume the additional cost requirement would not add significant burden to the currently approved 10 hours per application first established in the CY 2018 Quality Payment Program final rule (82 FR 30216)
